Oncopeptides AB (publ) (STO:ONCO)

Sweden flag Sweden · Delayed Price · Currency is SEK
4.795
+0.315 (7.03%)
Aug 26, 2025, 5:01 PM CET
7.03%
Market Cap1.01B
Revenue (ttm)50.87M
Net Income (ttm)-267.18M
Shares Out225.76M
EPS (ttm)-1.26
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,941,049
Average Volume5,656,439
Open4.480
Previous Close4.480
Day's Range4.380 - 4.820
52-Week Range1.100 - 6.960
Beta-1.13
RSI52.49
Earnings DateAug 21, 2025

About Oncopeptides AB

Oncopeptides AB (publ), a biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally. Its lead product candidate is Pepaxti (melflufen), a drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. The company’s PDC platform designed with two components, peptide carrier and a cytotoxic payload which utilizes the altered metabolism of cancer cells to hydrolyze PDC into active hyd... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 80
Stock Exchange Nasdaq Stockholm
Ticker Symbol ONCO
Full Company Profile

Financial Performance

In 2024, Oncopeptides AB's revenue was 31.65 million, a decrease of -10.14% compared to the previous year's 35.22 million. Losses were -284.61 million, 14.2% more than in 2023.

Financial Statements

News

Oncopeptides AB (STU:OND) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic Market ...

Oncopeptides AB (STU:OND) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic Market Focus

10 months ago - GuruFocus

Q3 2024 Oncopeptides AB Earnings Call Transcript

Q3 2024 Oncopeptides AB Earnings Call Transcript

10 months ago - GuruFocus

Oncopeptides AB (OSTO:ONCO) Q2 2024 Earnings Call Transcript Highlights: Revenue Surge and ...

Oncopeptides AB (OSTO:ONCO) Q2 2024 Earnings Call Transcript Highlights: Revenue Surge and Strategic Market Expansions

1 year ago - GuruFocus

Q2 2024 Oncopeptides AB Earnings Call Transcript

Q2 2024 Oncopeptides AB Earnings Call Transcript

1 year ago - GuruFocus